114 related articles for article (PubMed ID: 14975707)
1. Pre-weaning carvedilol treatment in spontaneously hypertensive rats.
Boesen EI; Lambert GW; Anderson WP; Kett MM
Eur J Pharmacol; 2004 Feb; 486(2):183-8. PubMed ID: 14975707
[TBL] [Abstract][Full Text] [Related]
2. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
Wong VY; Laping NJ; Nelson AH; Contino LC; Olson BA; Gygielko E; Campbell WG; Barone F; Brooks DP
Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Abdallah HH; Johns EJ
Eur J Pharmacol; 2009 Jun; 612(1-3):69-74. PubMed ID: 19356722
[TBL] [Abstract][Full Text] [Related]
5. Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Khan MA; Abdullah NA; Johns EJ
Acta Physiol (Oxf); 2009 Mar; 195(3):397-404. PubMed ID: 19183357
[TBL] [Abstract][Full Text] [Related]
6. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.
Kett MM; Denton KM; Boesen EI; Anderson WP
Am J Hypertens; 2004 Feb; 17(2):161-6. PubMed ID: 14751659
[TBL] [Abstract][Full Text] [Related]
7. Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists.
Dehner R; Ikeda K; Yamori Y; Grobecker H
Z Kardiol; 1990; 79 Suppl 3():79-88. PubMed ID: 1983053
[TBL] [Abstract][Full Text] [Related]
8. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of carvedilol infusion and the contribution of the sympathetic nervous system in rats with heart failure.
Abe Y; Watanabe K; Sato S; Nagai Y; Kamal FA; Wahed MI; Wen J; Narasimman G; Ma M; Suresh P; Takahashi T; Tachikawa H; Kashimura T; Tanabe N; Kodama M; Aizawa Y; Yamaguchi K; Miyazaki M; Kakemi M
Pharmacology; 2004 Dec; 72(4):213-9. PubMed ID: 15539880
[TBL] [Abstract][Full Text] [Related]
11. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
12. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
Okajima K; Harada N; Uchiba M; Isobe H
J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
[TBL] [Abstract][Full Text] [Related]
13. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
15. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
Tanaka M; Masumura H; Tanaka S; Akashi A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic treatment with carvedilol on smooth muscle tone and endothelium-dependent relaxation of aorta in stroke-prone spontaneously hypertensive rats.
Sunano S; Sekiguchi F; Nakamura A; Matsuda K; Yamamoto K; Shibutani T; Hashimoto H; Tanaka M; Shimamura K
J Smooth Muscle Res; 1997 Feb; 33(1):23-35. PubMed ID: 9127844
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats].
Ishimori T; Shiratsuchi K; Izumi A; Himori N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):463-9. PubMed ID: 6131020
[TBL] [Abstract][Full Text] [Related]
19. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
Hara Y; Nakahara H; Miyagishi A; Nakatani H
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
